Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Rating of “Buy” from Brokerages

by · The Cerbat Gem

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) have been given a consensus recommendation of “Buy” by the six ratings firms that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $9.88.

Several analysts have issued reports on the company. Oppenheimer cut their price objective on Bioceres Crop Solutions from $13.00 to $12.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 28th. Lake Street Capital decreased their price objective on shares of Bioceres Crop Solutions from $13.00 to $8.00 and set a “buy” rating for the company in a report on Friday, February 7th. Finally, Canaccord Genuity Group dropped their target price on shares of Bioceres Crop Solutions from $7.00 to $6.50 and set a “buy” rating on the stock in a report on Thursday, February 13th.

Read Our Latest Analysis on BIOX

Bioceres Crop Solutions Price Performance

Shares of BIOX stock opened at $4.13 on Friday. The firm has a fifty day moving average of $5.01 and a two-hundred day moving average of $6.26. The firm has a market cap of $259.00 million, a P/E ratio of 206.60 and a beta of 0.73. Bioceres Crop Solutions has a 1-year low of $3.69 and a 1-year high of $13.18. The company has a debt-to-equity ratio of 0.43, a current ratio of 1.33 and a quick ratio of 0.96.

Hedge Funds Weigh In On Bioceres Crop Solutions

Several hedge funds and other institutional investors have recently made changes to their positions in BIOX. Fourth Sail Capital LP increased its stake in shares of Bioceres Crop Solutions by 16.6% during the fourth quarter. Fourth Sail Capital LP now owns 3,698,961 shares of the company’s stock valued at $22,490,000 after acquiring an additional 527,859 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Bioceres Crop Solutions by 135.0% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 752,335 shares of the company’s stock valued at $4,574,000 after purchasing an additional 432,206 shares in the last quarter. Long Focus Capital Management LLC grew its position in Bioceres Crop Solutions by 130.7% in the fourth quarter. Long Focus Capital Management LLC now owns 744,748 shares of the company’s stock worth $4,528,000 after buying an additional 421,931 shares during the last quarter. Ballast Asset Management LP lifted its position in shares of Bioceres Crop Solutions by 23.5% during the 4th quarter. Ballast Asset Management LP now owns 431,887 shares of the company’s stock valued at $2,620,000 after acquiring an additional 82,187 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Bioceres Crop Solutions by 17.0% during the 4th quarter. JPMorgan Chase & Co. now owns 105,301 shares of the company’s stock worth $640,000 after acquiring an additional 15,328 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

(Get Free Report

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.

See Also